O'Riordan J - Search Results

1

Hepatitis E and blood donation safety in selected European countries: a shift to screening?

Domanović D, Tedder R, Blümel J, Zaaijer H, Gallian P, Niederhauser C, Sauleda Oliveras S, O'Riordan J, Boland F, Harritshøj L, Nascimento MSJ, Ciccaglione AR, Politis C, Adlhoch C, Flan B, Oualikene-Gonin W, Rautmann G, Strengers P, Hewitt P. Domanović D, et al. Euro Surveill. 2017 Apr 20;22(16):30514. doi: 10.2807/1560-7917.ES.2017.22.16.30514. Euro Surveill. 2017. PMID: 28449730 Free PMC article.

2

Hepatitis E virus infection in the Irish blood donor population.

O'Riordan J, Boland F, Williams P, Donnellan J, Hogema BM, Ijaz S, Murphy WG. O'Riordan J, et al. Transfusion. 2016 Nov;56(11):2868-2876. doi: 10.1111/trf.13757. Epub 2016 Aug 13. Transfusion. 2016. PMID: 27522065

3

Transfusion-transmitted hepatitis B virus (HBV) infection from an individual-donation nucleic acid (ID-NAT) non-reactive donor.

O'Flaherty N, Ushiro-Lumb I, Pomeroy L, Ijaz S, Boland F, De Gascun C, Fitzgerald J, O'Riordan J. O'Flaherty N, et al. Vox Sang. 2018 Apr;113(3):300-303. doi: 10.1111/vox.12633. Epub 2018 Feb 14. Vox Sang. 2018. PMID: 29441587

4

Inclusion of human immunodeficiency virus Type 2 (HIV-2) in a multiplex transcription-mediated amplification assay does not affect detection of HIV-1 and hepatitis B and C virus genotypes: a multicenter performance evaluation study.

Grabarczyk P, Koppelman M, Boland F, Sauleda S, Fabra C, Cambie G, Kopacz A, O'Riordan K, van Drimmelen H, O'Riordan J, Lelie N. Grabarczyk P, et al. Transfusion. 2015 Sep;55(9):2246-55. doi: 10.1111/trf.13193. Epub 2015 Jun 23. Transfusion. 2015. PMID: 26103564

5

Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation.

Lawlor E, Power J, Garson J, Yap P, Davidson F, Columb G, Smith D, Pomeroy L, O'Riordan J, Simmonds P, Tedder R. Lawlor E, et al. Vox Sang. 1999;76(3):138-43. doi: 10.1159/000031038. Vox Sang. 1999. PMID: 10341327

6

Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.

O'Riordan JM, Conroy A, Nourse C, Yap PL, McDonald GS, Kaminski G, Leong K, Lawlor E, Davoren A, Strong K, Davidson F, Lloyd A, Power J. O'Riordan JM, et al. Transfus Med. 1998 Dec;8(4):303-8. doi: 10.1046/j.1365-3148.1998.00172.x. Transfus Med. 1998. PMID: 9881424

7

Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.

Davoren A, Dillon AD, Power JP, Donnellan J, Quinn JM, Willis JW, Lawlor EM, O'Riordan JM. Davoren A, et al. Transfusion. 2002 Nov;42(11):1501-6. doi: 10.1046/j.1537-2995.2002.00224.x. Transfusion. 2002. PMID: 12421225

8

What would encourage blood donation in Ireland?

Harrington M, Sweeney MR, Bailie K, Morris K, Kennedy A, Boilson A, O'Riordan J, Staines A. Harrington M, et al. Vox Sang. 2007 May;92(4):361-7. doi: 10.1111/j.1423-0410.2007.00893.x. Vox Sang. 2007. PMID: 17456160

9

A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland.

Smith DB, Lawlor E, Power J, O'Riordan J, McAllister J, Lycett C, Davidson F, Pathirana S, Garson JA, Tedder RS, Yap PL, Simmonds P. Smith DB, et al. Vox Sang. 1999;76(3):175-80. doi: 10.1159/000031045. Vox Sang. 1999. PMID: 10341334 Clinical Trial.

10

Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin.

Laspina S, O'riordan JM, Lawlor E, Murphy WG. Laspina S, et al. Vox Sang. 2005 Jul;89(1):49-51. doi: 10.1111/j.1423-0410.2005.00637.x. Vox Sang. 2005. PMID: 15938740 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page